|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 430981-431030 of 2348419 (46969 Page(s) Totally)
<< < 8615 8616 8617 8618 8619 8620 8621 8622 8623 8624 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2017-10 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, SH;Yeh, KH;Wu, MS;Lin, CW;Wei, MF;Liou, JM;Wang, HP;Chen, LT;Cheng, AL |
| 臺大學術典藏 |
2018-09-10T18:04:32Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yeh, K.-H. and Wu, M.-S. and Lin, C.-W. and Wei, M.-F. and Liou, J.-M. and Wang, H.-P. and Chen, L.-T. and Cheng, A.-L.; JYH-MING LIOU; CHUNG-WU LIN; MING-SHIANG WU; ANN-LII CHENG |
| 臺大學術典藏 |
2020-03-03T03:36:41Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.;Yeh K.-H.;Wu M.-S.;Chung-Wu Lin;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Yeh K.-H.; Wu M.-S.; CHUNG-WU LIN; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Cheng A.-L.; Chen L.-T.; Wang H.-P.; Liou J.-M.; Wei M.-F.; Lin C.-W.; MING-SHIANG WU; Yeh K.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2021-02-02T02:21:00Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; MING-SHIANG WU; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-23T08:26:17Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Sung-Hsin Kuo;Yeh K.-H.;Wu M.-S.;Lin C.-W.;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; SUNG-HSIN KUO; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:29:32Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-15T03:46:33Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; HSIU-PO WANG; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.;Kun-Huei Yeh;Wu M.-S.;Lin C.-W.;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; KUN-HUEI YEH; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-27T08:20:46Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; JYH-MING LIOU; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 國立成功大學 |
2017 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H.;Yeh, K.-H.;Wu, M.-S.;Lin, C.-W.;Wei, M.-F.;Liou, J.-M.;Wang, H.-P.;Chen, L.-T.;Cheng, A.-L. |
| 臺大學術典藏 |
2020-08-12T06:34:32Z |
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
|
Geater S.L.; Wolf J.; Paz-Ares L.; Soria J.-C.; Tan D.S.W.; Chiari R.; Wu Y.-L.; Soria J.-C.;Tan D.S.W.;Chiari R.;Wu Y.-L.;Paz-Ares L.;Wolf J.;Geater S.L.;Orlov S.;Cortinovis D.;Chong-Jen Yu;Hochmair M.;Cortot A.B.;Tsai C.-M.;Moro-Sibilot D.;Campelo R.G.;Mcculloch T.;Sen P.;Dugan M.;Pantano S.;Branle F.;Massacesi C.;De Castro G.;Jr; Orlov S.; Cortinovis D.; CHONG-JEN YU; Hochmair M.; Cortot A.B.; Tsai C.-M.; Moro-Sibilot D.; Campelo R.G.; McCulloch T.; Sen P.; Dugan M.; Pantano S.; Branle F.; Massacesi C.; de Castro G.; Jr |
| 臺大學術典藏 |
2022-06-27T07:00:11Z |
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
|
Soria J.-C.; Tan D.S.W.; Chiari R.; Wu Y.-L.; Paz-Ares L.; Wolf J.; Geater S.L.; Orlov S.; Cortinovis D.; CHONG-JEN YU; Hochmair M.; Cortot A.B.; Tsai C.-M.; Moro-Sibilot D.; Campelo R.G.; McCulloch T.; Sen P.; Dugan M.; Pantano S.; Branle F.; Massacesi C.; de Castro G.; Jr |
| 國立臺灣大學 |
2014 |
First-line Combination Therapy with Rituximab and Corticosteroids is Effective and Safe for Pemphigus
|
Cho, Yung-Tsu; Lee, Fang-Yu; Chu, Chia-Yu; Wang, Li-Fang |
| 臺大學術典藏 |
2019-12-04T08:43:43Z |
First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus
|
Cho Y.-T.;Lee F.-Y.;Chia-Yu Chu;Wang L.-F.; Cho Y.-T.; Lee F.-Y.; CHIA-YU CHU; Wang L.-F. |
| 國立臺灣大學 |
2015 |
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
|
Cho, Y. T.; Chu, C. Y.; Wang, L. F.; 王莉芳 |
| 臺大學術典藏 |
2015 |
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
|
Cho, Y.T.;Chu, C.Y.;Wang, L.F.; LI-FANG WANG; CHIA-YU CHU |
| 臺大學術典藏 |
2019-12-04T08:43:40Z |
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
|
Wang L.F.; Cho Y.T.; CHIA-YU CHU; Cho Y.T.;Chia-Yu Chu;Wang L.F. |
| 國立成功大學 |
2016-08 |
First-Line Disease Modifying Therapies in Preventing Multiple Sclerosis Relapse - A Nationwide Observational Study in Taiwan
|
Chou, Chih-Ho; Lin, Tzu-Chieh; Cheng, Ching-Lan; Yang, Yea-Huei Kao |
| 臺大學術典藏 |
2022-06-27T07:00:23Z |
First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer the ASPIRATION study
|
Park K.; CHONG-JEN YU; Kim S.-W.; Lin M.-C.; Sriuranpong V.; Tsai C.-M.; Lee J.-S.; Kang J.-H.; Chan K.C.A.; Perez-Moreno P.; Button P.; Ahn M.-J.; Mok T. |
| 國家衛生研究院 |
2018-01 |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo, YH;Shiu, SI;Ho, HJ;Zou, B;Lin, JT;Wu, MS;Liou, JM;Wu, CY;Consortium, Taiwan Gastrointestinal Disease and Helicobacter |
| 臺大學術典藏 |
2018-09-10T18:04:31Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis
|
Yeo, Y.H. and Shiu, S.-I. and Ho, H.J. and Zou, B. and Lin, J.-T. and Wu, M.-S. and Liou, J.-M. and Wu, C.-Y.; JYH-MING LIOU; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:18Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Wu C.-Y.; Liou J.-M.; MING-SHIANG WU; Lin J.-T.; Zou B.; Ho H.J.; Shiu S.-I.; Yeo Y.H. |
| 臺大學術典藏 |
2021-02-02T02:20:59Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; MING-SHIANG WU; Liou J.-M.; Wu C.-Y. |
| 臺大學術典藏 |
2021-05-27T08:20:46Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y. |
| 國立臺灣大學 |
2013 |
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments
|
Liao, Bin-Chi; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新 |
| 臺大學術典藏 |
2020-05-26T09:27:03Z |
First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments
|
Liao B.-C;Lin C.-C;Chih-Hsin Yang; Liao B.-C; Lin C.-C; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T07:35:25Z |
First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments
|
Liao B.-C; Chia-Chi Lin; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-20T08:00:43Z |
First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments
|
BIN-CHI LIAO; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-26T09:26:49Z |
First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results from a Randomized Phase III Trial
|
Chih-Hsin Yang;Rajan N;Kim J.S;Puri T;Orlando M;Tsai C.-M;Kang J.H;Srimuninnimit V;Wang X;Boye M; Boye M; Wang X; Srimuninnimit V; Kang J.H; Tsai C.-M; Orlando M; Puri T; Kim J.S; Rajan N; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
|
Chia-Chi Lin; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.; Srimuninnimit V; Ahn M.-J; Mok T; Kang J.H; Yang J.C.-H |
| 臺大學術典藏 |
2020-05-26T09:26:59Z |
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
|
CHIH-HSIN YANG; Kang J.H; Mok T; Ahn M.-J; Srimuninnimit V; Lin C.-C; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K. |
| 國立臺灣大學 |
2016 |
First-line ribociclib plus letrozole in postmenopausal Asian women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2
|
Yap, Y. S.; Tseng, L-M.; Blackwell, K. L.; Cameron, D.; Foo, S.; Sriuranpong, V.; Huang, C-S.; Chao, T-Y.; Kim, T-Y.; Chen, S-C.; Jung, K. H.; Lee, K. S.; Sohn, J-H.; Kim, J. H.; Hou, M-F.; Han, Y.; Souami, F.; Dhuria, S.; Miller, M.; Verma, S.; 黃俊升 |
| 臺大學術典藏 |
2019-11-18T07:58:09Z |
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
|
JIN-TUNG LIANG;Liauw, Winston;KATHERINE ANN KIM;KATHERINE ANN KIM;I-RUE LAI;KAI-PING GRACE YAO;KAI-PING GRACE YAO;D. Adam;BEI-EN CHANG;BAU-RUEI DUH;AN-BANG WANG;RICHARD PING CHENG;BEI-EN CHANG;ADRIAN RAUCHFLEISCH;GRACE PEN-HSIU CHAO;Lammert, Frank;Kr?ning, Hendrik;Ko, Yon Dschun;Karapetis, Chris;James, Philip;Jackson, Christopher;Holtzman, Matthew;Hendrickx, Koen;Hendlisz, Alain;Helmberger, Thomas;Heching, Norman;van Hazel, Guy;Hannigan, James;Gulec, Seza;Gordon, Michael;Geva, Ravit;George, Benjamin;Gehbauer, Gerald;Garofalo, Michael;Ganju, Vinod;Frick, Jacob;Frenette, Gary;Ferrante, Michel;Ferguson, Thomas;Facchini, Francis;Eliadis, Paul;Delanoit, Thierry;Craninx, Michael;Coveler, Andrew;Clarke, Stephen;Chuong, Michael;Chevallier, Patrick;Chen, Yi Jen;Chai, Seungjean;Carlisle, James;Cardaci, Giuseppe;Burge, Matthew;Bui, James;Bruch, Harald Robert;Beny, Alex;Balosso, Jacques;Amin, Pradip;Wilson, Greg;Walther, Axel;Swinson, Daniel;Soomal, Rubin;Smith, David;Sherwin, Liz;Sharma, Ricky A.;Purcell, Colin;Polychronis, Andreas;Muirhead, Rebecca;Montazeri, Amir;Middleton, Gary;Metcalfe, Matthew;Mayer, Astrid;Lowndes, Sarah;Lofts, Fiona;Hornbuckle, Joanne;Hickish, Tamas;Hall, Marcia;Hadaki, Maher;Falk, Stephen;Cunningham, David;Cummins, Sebastian;Chau, Ian;Blesing, Claire;Bateman, Andrew;Gray, Alastair;Gebski, Val;Love, Sharon;Dutton, Peter;Virdee, Pradeep S.;Moschandreas, Joanna;Francis, Anne;Wilson, Charles;Mills, Jamie;Weaver, Andrew;Findlay, Michael;Peeters, Marc;Ricke, Jens;Heinemann, Volker;Taieb, Julien;Sharma, Navesh K.;Wasan, Harpreet S.; Wasan, Harpreet S.; GRACE PEN-HSIU CHAO; Sharma, Navesh K.; Taieb, Julien; Heinemann, Volker; Ricke, Jens; Peeters, Marc; Findlay, Michael; Weaver, Andrew; Mills, Jamie; Wilson, Charles; ADRIAN RAUCHFLEISCH; Francis, Anne; Moschandreas, Joanna; Virdee, Pradeep S.; Dutton, Peter; Love, Sharon; Gebski, Val; Gray, Alastair; Bateman, Andrew; Blesing, Claire; BEI-EN CHANG; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; James, Philip; KATHERINE ANN KIM; Karapetis, Chris; KATHERINE ANN KIM; Ko, Yon Dschun; Kr?ning, Hendrik; Lammert, Frank; Liauw, Winston; JIN-TUNG LIANG; Purcell, Colin; RICHARD PING CHENG; Sharma, Ricky A.; Sherwin, Liz; Smith, David; Soomal, Rubin; Swinson, Daniel; Walther, Axel; Wilson, Greg; Amin, Pradip; AN-BANG WANG; Balosso, Jacques; Beny, Alex; BAU-RUEI DUH; BEI-EN CHANG; Bruch, Harald Robert; Bui, James; Burge, Matthew; Cardaci, Giuseppe; Carlisle, James; Chai, Seungjean; Chen, Yi Jen; Chevallier, Patrick; Chuong, Michael; Clarke, Stephen; Coveler, Andrew; Craninx, Michael; Delanoit, Thierry; D. Adam; Eliadis, Paul; Facchini, Francis; Ferguson, Thomas; Ferrante, Michel; Frenette, Gary; Frick, Jacob; Ganju, Vinod; Garofalo, Michael; KAI-PING GRACE YAO; Gehbauer, Gerald; George, Benjamin; Geva, Ravit; Gordon, Michael; KAI-PING GRACE YAO; Gulec, Seza; Hannigan, James; van Hazel, Guy; Heching, Norman; Helmberger, Thomas; Hendlisz, Alain; Hendrickx, Koen; Holtzman, Matthew; I-RUE LAI; Jackson, Christopher; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Montazeri, Amir; Muirhead, Rebecca; Polychronis, Andreas |
| 臺大學術典藏 |
2021-05-03T02:20:50Z |
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
|
Wasan H.S.; Gibbs P.; Sharma N.K.; Taieb J.; Heinemann V.; Ricke J.; Peeters M.; Findlay M.; Weaver A.; Mills J.; Wilson C.; Adams R.; Francis A.; Moschandreas J.; Virdee P.S.; Dutton P.; Love S.; Gebski V.; Gray A.; Bateman A.; Blesing C.; Brown E.; Chau I.; Cummins S.; Cunningham D.; Falk S.; Hadaki M.; Hall M.; Hickish T.; Hornbuckle J.; Lofts F.; Lowndes S.; Mayer A.; Metcalfe M.; Middleton G.; Montazeri A.; Muirhead R.; Polychronis A.; Purcell C.; Ross P.; Sharma R.A.; Sherwin L.; Smith D.; Soomal R.; Swinson D.; Walther A.; Wilson G.; Amin P.; Angelelli B.; Balosso J.; Beny A.; Bloomgarden D.; Boucher E.; Bruch H.-R.; Bui J.; Burge M.; Cardaci G.; Carlisle J.; Chai S.; Chen Y.-J.; Chevallier P.; Chuong M.; Clarke S.; Coveler A.; Craninx M.; Delanoit T.; Deleporte A.; Eliadis P.; Facchini F.; Ferguson T.; Ferrante M.; Frenette G.; Frick J.; Ganju V.; Garofalo M.; Geboes K.; Gehbauer G.; George B.; Geva R.; Gordon M.; Gregory K.; Gulec S.; Hannigan J.; van Hazel G.; Heching N.; Helmberger T.; Hendlisz A.; Hendrickx K.; Holtzman M.; Isaacs R.; Jackson C.; James P.; Kaiser A.; Karapetis C.; Kaubisch A.; Ko Y.-D.; Kr?ning H.; Lammert F.; Liauw W.; Limentani S.; Louafi S.; de Man M.; Margolis J.; Martin R.; Martoni A.; Marx G.; Matos M.; Monsaert E.; Moons V.; Nott L.; Nusch A.; O'Donnell A.; Ozer H.; Padia S.; Pavlakis N.; Perez D.; Pluntke S.; Polus M.; Powell A.; Pracht M.; Price T.; Ransom D.; Rebischung C.; Ridwelski K.; Riera-Knorrenschild J.; Riess H.; Rilling W.; Robinson B.; Rodr?guez J.; Sanchez F.; Sauerbruch T.; Savin M.; Scheidhauer K.; Schneiderman E.; Seeger G.; Segelov E.; Schmueli E.S.; Shani A.; Shannon J.; Shibata S.; Singhal N.; Smith D.; Smith R.; Stemmer S.; St?tzer O.; Strickland A.; Tatsch K.; Terrebonne E.; Tichler T.; Vehling-Kaiser U.; Vera-Garcia R.; Vogl T.; Walpole E.; Wang E.; Whiting S.; Wolf I.; Ades S.; Aghmesheh M.; Auber M.; Ayala H.; Boland P.; Bouche E.; Bowers C.; Bremer C.; Casado A.R.; Cooray P.; Crain M.; De Wit M.; Dowling K.; Durand A.; Faivre S.; Feeney K.; Ferru A.; Fragoso M.; Granetto C.; Hammel P.; Issacs R.; Iyer R.; Kim Y.H.; JIN-TUNG LIANG; Lim L.; Liu J.H.; Masi G.; Mosconi S.; Numico G.; Ratner L.; Sae-Won H.; Singh M.; Stoltzfus P.; Tan I.; Trogu A.; Underhill C.; Westcott M.; FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, FOXFIRE-Global trial investigators |
| 臺北醫學大學 |
2011-06 |
First-line Systemic Therapy for Metastatic Non-small-cell Lung Cancer e A Review
|
Yuh-Min Chen, Jacqueline Whang-Peng, Chien-Ming Chen |
| 臺大學術典藏 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S |
| 國立臺灣大學 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2020-05-26T09:27:20Z |
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
|
Soo R.A;Anderson B.O;Cho B.C;Chih-Hsin Yang;Liao M;Lim W.-T;Goldstraw P;Mok T.S.; Soo R.A; Anderson B.O; Cho B.C; CHIH-HSIN YANG; Liao M; Lim W.-T; Goldstraw P; Mok T.S. |
| 國立成功大學 |
2022 |
First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study
|
Huang;L, -y.;Chang;H, -p.;Chang;R, -y.;Tai;H, -y.;Huang;Y, -w.;Lee;P, -c. |
| 國立成功大學 |
2021-02 |
First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer
|
Su;Po-Lan;Chen;Chian-Wei;Wu;Yi-Lin;Lin;Chien-Chung;Su;Wu-Chou |
| 臺大學術典藏 |
2020-03-06T03:42:39Z |
First-mover strategy, resource capacity alignment, and new product performance: a framework for mediation and moderation effects
|
Hsiao Y.-C.;Chen C.-J.;Guo R.-S.;Hu K.-K.; Hsiao Y.-C.; Chen C.-J.; Guo R.-S.; Hu K.-K.; RUEY-SHAN GUO |
| 臺大學術典藏 |
2020-03-06T03:40:53Z |
First-mover strategy, resource capacity alignment, and new product performance: a framework for mediation and moderation effects
|
Hsiao Y.-C.;Chen C.-J.;Guo R.-S.;Hu K.-K.; Hsiao Y.-C.; Chen C.-J.; Guo R.-S.; Hu K.-K.; CHUNG-JEN CHEN |
| 國立交通大學 |
2014-12-08T15:01:54Z |
First-order analysis of a three-lens afocal zoom system
|
Yeh, MS; Shiue, SG; Lu, MH |
| 國立交通大學 |
2019-04-03T06:38:48Z |
First-order analysis of a three-lens afocal zoom system
|
Yeh, MS; Shiue, SG; Lu, MH |
| 國立交通大學 |
2014-12-08T15:49:22Z |
First-order analysis of a three-lens zoom system with the last lens fixed
|
Yeh, MS; Shiue, SG; Lu, MH |
| 國立交通大學 |
2014-12-08T15:02:15Z |
First-order analysis of a two-conjugate zoom system
|
Yeh, MS; Shiue, SG; Lu, MH |
| 臺大學術典藏 |
2020-07-16T02:45:42Z |
First-order assessment of gas reserves in the lower Fangliao basin gas hydrate prospect, offshore southwest Taiwan
|
Liu, C.; Lin, A.T.; Dirgantara, F. |
| 國立成功大學 |
2019-11-25 |
First-order derivative matrix of a ray: a simple and flexible alternative computation method
|
Lin;Dain, Psang |
| 東方設計學院 |
2008-10-02 |
First-order derivative spectrophotometry of intermediates in the TiO2-assisted photocatalysis of phenol under ultraviolet irradiation
|
Sun, Yun-Yun; Liu, Yi-Hsin; Lai, Teh- Long; Shu, Youn-Yuen; 孫昀妘; (東方技術學院化妝品應用與管理系) |
Showing items 430981-431030 of 2348419 (46969 Page(s) Totally)
<< < 8615 8616 8617 8618 8619 8620 8621 8622 8623 8624 > >>
View [10|25|50] records per page
|
